Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Diagnostics allow for the identification of cancer types and other crucial biomarkers, and are used right through from discovery to market.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics:
Prenatal gene therapy has been used to prevent acute neuronopathic Gaucher’s disease, however this approach is using viruses to deliver normal copies of genes.
The debate about the pros and cons of genetically screening embryos is deeply entrenched. Perhaps we should let couples decide?
Verge Genomics, the drug discovery startup we recently featured in our Top 5 Startups Disrupting Healthcare, has raised $32 million in Series A financing.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
One year after researchers published their work on a physiological test for autism, a follow-up study has confirmed its exceptional success in assessing whether a child is on the autism spectrum.
Scientists are taking advantage of the “self-homing” abilities of cancer cells and are creating armies of cancer-killing cells using CRISPR gene-editing.
A small pilot study presented at the European Society for Human Reproduction and Embryology 2018, suggest that DNA shed from early embryos could one day provide an alternative way of genetically testing them without having to do a biopsy.
The US Health and Human Services Secretary Alex Azar has approved adding a test for spinal muscular atrophy to the list of recommended newborn screens in the United States.
Phenotyping trailblazers are proving an impressive success in the clinic as the continue to go from strength to strength.